STOCK TITAN

Eason Technology Limited Received NYSE American Non-Compliance Letter

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags

Eason Technology (NYSE: DXF) received a notice from NYSE American on October 14, 2025, that it is not in compliance with Section 1003(a)(ii) of the NYSE American Company Guide.

The Company reported stockholders' equity of RMB 28 million (≈ USD 3.8 million) as of December 31, 2024 and recorded losses in three of its four most recent fiscal years. Eason is not currently eligible for an equity exemption and must submit a compliance plan by November 13, 2025 to regain compliance by April 14, 2027. If no acceptable plan is filed or the company fails to meet the plan, delisting proceedings may follow. The Company's ADSs will remain listed and tradable during the cure period, subject to other listing requirements.

Eason Technology (NYSE: DXF) ha ricevuto una comunicazione da NYSE American il 14 ottobre 2025, che indica non conformità alla Sezione 1003(a)(ii) della NYSE American Company Guide.

L'azienda ha riportato un patrimonio netto degli azionisti di RMB 28 milioni (circa USD 3,8 milioni) al 31 dicembre 2024 e ha registrato perdite in tre dei quattro esercizi finanziari più recenti. Eason non è attualmente idonea per un'eccezione di capitale proprio e deve presentare un piano di conformità entro 13 novembre 2025 per riconquistare la conformità entro 14 aprile 2027. Se nessun piano accettabile viene presentato o la società non riesce a rispettare il piano, potrebbero avviarsi procedure di delisting. Le ADS della Società rimarranno quotate e negoziabili durante il periodo di correzione, soggette agli altri requisiti di quotazione.

Eason Technology (NYSE: DXF) recibió una notificación de NYSE American el 14 de octubre de 2025 de que no cumple con la Sección 1003(a)(ii) de la NYSE American Company Guide.

La Compañía reportó un patrimonio de los accionistas de RMB 28 millones (aprox. USD 3,8 millones) al 31 de diciembre de 2024 y registró pérdidas en tres de sus cuatro ejercicios fiscales más recientes. Eason no es actualmente elegible para una exención de capital y debe presentar un plan de cumplimiento antes del 13 de noviembre de 2025 para volver a cumplir antes del 14 de abril de 2027. Si no se presenta un plan aceptable o la compañía no logra cumplirlo, pueden iniciarse procedimientos de retirada. Las ADS de la Compañía seguirán cotizando y siendo negociables durante el período de cure, sujeto a otros requisitos de cotización.

Eason Technology (NYSE: DXF)가 2025년 10월 14일 NYSE American으로부터 NYSE American Company Guide의 섹션 1003(a)(ii)를 준수하지 않는다는 통지를 받았습니다.

회사는 2024년 12월 31일 기준 주주지분 2800만 RMB(약 380만 달러)를 보고했고, 최근 4개 회계연도 중 3개에서 손실을 기록했습니다. Eason은 현재 자본 예외를 받을 자격이 없으며 준수를 되찾기 위해 2025년 11월 13일까지 준수계획을 제출해야 하며, 2027년 4월 14일까지 준수하도록 해야 합니다. 수용 가능한 계획이 제출되지 않거나 회사가 계획을 이행하지 않으면 상장폐지 절차가 진행될 수 있습니다. 회사의 ADS는 치료기간 동안 상장된 상태로 남아 거래되며, 기타 상장 요건의 적용을 받습니다.

Eason Technology (NYSE: DXF) a reçu le 14 octobre 2025 une notification de NYSE American indiquant qu’elle n’est pas conforme à la Section 1003(a)(ii) du NYSE American Company Guide.

La société a déclaré un fonds propres des actionnaires de 28 millions de RMB (environ 3,8 millions USD) au 31 décembre 2024 et a enregistré des pertes au cours de trois de ses quatre exercices fiscaux les plus récents. Eason n’est pas actuellement éligible à une exemption de fonds propres et doit soumettre un plan de conformité d’ici le 13 novembre 2025 pour regagner la conformité d’ici le 14 avril 2027. Si aucun plan acceptable n’est déposé ou si la société ne respecte pas le plan, des procédures de radiation pourraient suivre. Les ADS de la Société resteront listées et négociables pendant la période de cure, sous réserve des autres exigences de cotation.

Eason Technology (NYSE: DXF) erhielt am 14. Oktober 2025 von der NYSE American eine Mitteilung, dass sie nicht mit Abschnitt 1003(a)(ii) des NYSE American Company Guide übereinstimmt.

Das Unternehmen meldete Eigenkapital der Aktionäre von RMB 28 Millionen (ca. USD 3,8 Millionen) zum 31. Dezember 2024 und verzeichnete Verluste in drei der vier jüngsten Geschäftsjahre. Eason ist derzeit nicht berechtigt für eine Eigenkapitalausnahme und muss bis zum 13. November 2025 einen Compliance-Plan einreichen, um die Konformität bis zum 14. April 2027 wiederherzustellen. Wird kein akzeptabler Plan eingereicht oder erfüllt das Unternehmen den Plan nicht, können Delisting-Verfahren folgen. Die ADS des Unternehmens bleiben während der Heilungsfrist gelistet und handelbar, vorbehaltlich anderer Listing-Anforderungen.

Eason Technology (NYSE: DXF) تلقّت إشعاراً من NYSE American في 14 أكتوبر 2025 يشير إلى أنها لا تمتثل للفقرة 1003(a)(ii) من دليل NYSE American Company.

أبلغت الشركة عن حقوق المساهمين للمساهمين البالغة 28 مليون يوان صيني (حوالي 3.8 ملايين دولار أمريكي) حتى 31 ديسمبر 2024 وسجّلت خسائر في ثلاثة من أرباع أعوامها المالية الأربعة الأخيرة. ليس لدى Eason حالياً أهلية لاستثناء حقوق الأسهم ويجب عليها تقديم خطة امتثال بحلول 13 نوفمبر 2025 لاستعادة الامتثال بحلول 14 أبريل 2027. إذا لم يتم تقديم خطة مقبولة أو فشلت الشركة في تنفيذ الخطة، قد تتبع إجراءات إدراج. ستظل ADSs الخاصة بالشركة مدرجة وقابلة للتداول خلال فترة الإصلاح، مع مراعاة متطلبات الإدراج الأخرى.

Eason Technology (NYSE: DXF) 于 2025 年 10 月 14 日收到 NYSE American 的通知,表示其未符合 NYSE American Company Guide 第 1003(a)(ii) 条款。

公司报道 截至 2024 年 12 月 31 日的股东权益为人民币 2800 万元(约合 380 万美元),并在最近四个财年中有三年出现亏损。Eason 目前不具备股本豁免资格,必须在 2025 年 11 月 13 日前提交合规计划,以在 2027 年 4 月 14 日前重新达到合规。如果未提交可接受的计划,或公司未能按计划执行,可能会启动退市程序。在 cure 期内,公司 的 ADS 将维持上市并可交易,但需遵守其他上市要求。

Positive
  • ADS listing will continue during the cure period
  • Plan submission deadline set for November 13, 2025
Negative
  • Stockholders' equity RMB 28 million as of December 31, 2024
  • Equity ≈ USD 3.8 million based on RMB7.2993/USD
  • Losses in three of four fiscal years ended December 31, 2024
  • Compliance deadline April 14, 2027 or delisting proceedings

Insights

Notice cites low shareholders' equity and multi-year losses; company must file a recovery plan by November 13, 2025.

Eason Technology faces a formal non-compliance finding under Section 1003(a)(ii) after reporting RMB 28 million (about USD 3.8 million) in stockholders' equity as of December 31, 2024, and losses in three of its four most recent fiscal years. The Exchange requires a written plan addressing how the company will regain compliance.

The firm must submit a plan by November 13, 2025 and reach compliance by April 14, 2027, or face delisting procedures. The ADSs remain listed during the cure period, but the filing obligation and potential delisting create an increased regulatory and execution risk for the company through the compliance window.

Watch the submitted plan and any Exchange response between now and November 13, 2025, then monitor documented progress toward the April 14, 2027 deadline. Key facts to track are acceptance of the plan and any interim milestones the Exchange requires.

HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE: DXF) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange") on October 14, 2025. The Company is below compliance with Section 1003(a)(ii) of the NYSE American Company Guide (the "Company Guide") since it reported stockholders' equity of RMB 28 million (approximately USD$3.8 million based on an exchange rate of RMB 7.2993 to US$1.00) as of December 31, 2024, and losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December 31, 2024 (the "Deficiency"). The Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide from the stockholders' equity requirements.

The Company is now subject to the procedures and requirements set forth in Section 1009 of the Company Guide. In connection with its Deficiency, the Company must submit a plan by November 13, 2025 ("Plan Due Date"), advising of actions it has taken or will take to regain compliance with the continued listing standards by April 14, 2027 ("Compliance Deadline").

If the Company does not submit a compliance plan or if the plan is not accepted, delisting proceedings will commence. Furthermore, if the plan is accepted but the Company is not in compliance with the continued listing standards by the Compliance Deadline, or if the Company does not make progress consistent with the plan during the plan period, Exchange staff will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide.

This delinquency notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

About Eason Technology Limited

Eason Technology Limited is a company engaged in real estate operation management and investment and digital technology security business in Hong Kong, China. The Company was formerly a licensed microfinance lender serving individuals and SMEs in Hubei Province, China, but has suspended offering loans to its customers since 2020.

Safe Harbor Statement

Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.

Media Contact: 

Mark Xu
ir@dunxin.us

Cision View original content:https://www.prnewswire.com/news-releases/eason-technology-limited-received-nyse-american-non-compliance-letter-302589305.html

SOURCE Eason Technology Limited

FAQ

What did Eason Technology (DXF) receive from NYSE American on October 14, 2025?

Eason Technology received a notice that it is not in compliance with Section 1003(a)(ii) due to low equity and multi-year losses.

How much stockholders' equity did Eason Technology report for 2024 (DXF)?

The company reported RMB 28 million, approximately USD 3.8 million using the stated exchange rate.

When is Eason Technology's compliance plan due for NYSE American (DXF)?

The compliance plan must be submitted by November 13, 2025.

What is the NYSE American compliance deadline for Eason Technology (DXF)?

The Company must regain compliance by April 14, 2027 or face potential delisting proceedings.

Will Eason Technology's ADSs stop trading immediately after the notice (DXF)?

No; the ADSs will remain listed and tradable during the cure period, subject to other listing requirements.
Eason Technology

NYSE:DXF

DXF Rankings

DXF Latest News

DXF Latest SEC Filings

DXF Stock Data

4.33M
1.38M
17.43%
12.25%
Credit Services
Financial Services
Link
China
Wuhan